ASX extends program
The ASX has extended its trial equity research subsidy program for another year after 60per cent of the companies covered reported an increase in turnover of their securities in the past 12 months.
The ASX has extended its trial equity research subsidy program for another year after 60per cent of the companies covered reported an increase in turnover of their securities in the past 12 months. The scheme was introduced to help smaller companies get analyst coverage, and for larger research houses to cover companies they would otherwise ignore.
